Individual and joint associations of urinary phthalate metabolites with polycystic ovary and polycystic ovary syndrome: Results from the TREE cohort

Environ Toxicol Pharmacol. 2023 Sep:102:104233. doi: 10.1016/j.etap.2023.104233. Epub 2023 Jul 19.

Abstract

Phthalates are widespread endocrine disrupting chemicals that adversely affect female reproductive health. We aimed to investigate the individual and joint associations of phthalate exposures measured by repeated urinary metabolites with polycystic ovary (PCO) and polycystic ovary syndrome (PCOS) (96 PCO cases, 96 PCOS cases and 370 controls). In single-pollutant analyses, mono-isobutyl phthalate (MiBP), monobenzyl phthalate (MBzP) and the sum of di(2-ethylhexyl) phthalate (∑DEHP) were associated with increased prevalence of PCO. Mono(2-ethylhexyl) phthalate (MEHP), MBzP and ∑DEHP were associated with elevated prevalence of PCOS. In multiple-pollutant analyses, one-quartile increase of weighted quantile sum index in phthalate metabolite mixtures was associated with increased prevalence of PCO and PCOS, and MBzP was the most major contributor. Our findings suggest a potential role for phthalate exposures, both individually and in mixtures, in the development of PCO and PCOS.

Keywords: Phthalate metabolite mixture; Phthalates; Polycystic ovary; Polycystic ovary syndrome.

MeSH terms

  • Environmental Exposure
  • Environmental Pollutants* / toxicity
  • Environmental Pollutants* / urine
  • Female
  • Humans
  • Phthalic Acids* / toxicity
  • Phthalic Acids* / urine
  • Polycystic Ovary Syndrome* / chemically induced

Substances

  • phthalic acid
  • Phthalic Acids
  • Environmental Pollutants
  • mono-(2-ethylhexyl)phthalate